CVE-2026-24222: nvidia nemoclaw
Vulnerability summary
CVE-2026-24222 is a high (CVSS 8.6) vulnerability in nvidia nemoclaw. EPSS estimates a 0.40% chance of exploitation in the next 30 days, higher than 32.1% of scored vulnerabilities.
Timeline
- 28-04-2026PublishedVulnerability first disclosed.
- 29-04-2026Last modifiedVulnerability information updated.
Description
NVIDIA NeMoClaw contains a vulnerability in the sandbox environment initialization component, where a remote attacker could cause improper access control by sending prompt-injected content that causes the agent to read and exfiltrate host environment variables not properly restricted during sandbox creation. A successful exploit of this vulnerability might lead to information disclosure.
CVSS metrics
2 scores · 2 sources · 1 version- NVDNIST8.6HighCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:N
EPSS trend
Probability
0.40%
Chance of exploitation in the next 30 days
Percentile
32%
Versus all other CVEs
30-day change
0.00 pp
From 0.40% on 19-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Nvidia1 product
- nemoclawAll versions prior to v0.0.18 | < 0.0.18
1 vendor · 1 product
References
3 links- nvd.nist.gov/vuln/detail/CVE-2026-24222US Government Resource
- www.cve.org/CVERecord?id=CVE-2026-24222Third Party Advisory
- nvidia.custhelp.com/app/answers/detail/a_id/5837Vendor Advisory